ALD Connect is hosting an Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting with the FDA on July 22, 2022, targeting ALD in adulthood. We need members of the ALD community to be involved to make this meeting a success. Please join us for a community webinar on March 29th at 4pm EDT to learn how you can get involved!